Octagon Capital Advisors LP Cabaletta Bio, Inc. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
A detailed history of Octagon Capital Advisors LP transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 52,000 shares of CABA stock, worth $388,960. This represents 0.14% of its overall portfolio holdings.
Number of Shares
52,000Holding current value
$388,960% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
168Shares Held
48.8MCall Options Held
300KPut Options Held
1.31M-
Black Rock Inc. New York, NY4.06MShares$30.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$28 Million0.0% of portfolio
-
Jennison Associates LLC3.42MShares$25.6 Million0.04% of portfolio
-
Fred Alger Management, LLC New York, NY3.11MShares$23.3 Million0.27% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$22.7 Million0.1% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $217M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...